Oslo - December 20, 2022: The Board of Directors of SoftOx Solutions AS
("SoftOx" or the "Company"), a medtech and clinical-stage pharmaceutical company
based in Oslo, Norway, announces that Christian Harstad has been appointed as
the Interim Chief Executive Officer. 

Christian Harstad has a long military career including serving as a submarine
commanding officer and roles in the Norwegian special forces, US Joint Forces
Command, US Naval War College, Norwegian Defence Staff, and the Norwegian
Ministry of Defence. He retired from the Military as Flag Officer and
second-in-command for Norwegian Special Operations Forces. In September 2022,
Harstad joined SoftOx as the Project Director for SoftOx Defense Solutions AS.

Geir Almås, Executive Chairman of the Board, said "As recently published, I will
step down from my current role as CEO and transition to Executive chairman of
SoftOx and to focus my efforts on funding and strategic development of the
company. Based on Harstad's background, prior experience, skill set and
extensive network, I feel confident that he is a very good candidate for the
job. We are thrilled to have recruited him to lead the company as it embarks on
its next strategic steps for collaboration with major defence institutions
including the European Defence Fund (EDF) and the US Naval Medical Research
Center."

Christian Harstad added: "I am very pleased that Geir and the Board have given
me this opportunity. SoftOx is in a unique position both on the wound care and
the infectious disease segments. Working together with Geir, I believe we have a
strategy that will move the company forward in a very interesting market. In the
infectious disease segment, we have established ourselves as one of the main
technologies in a consortium with the backing of EU whereas we are working
together with the US Naval Medical Research Center on the development of
treatment for chronic wounds. With partners like these, we have positioned the
Company well and laid the groundwork for bringing very important capabilities to
the military and civilian market."

Christian Harstad will commence as interim CEO on January 1, 2023. 

In addition, the Company's Chief Financial Officer Kristine Rød is leaving the
company in order to pursue other opportunities.  As of January 1, 2023, Harald
Sætvedt will be the company's CFO. 

"I am very happy to welcome Harald Sætvedt as our new CFO.  Sætvedt has worked
with SoftOx on strategic questions for two years and knows the company well.
With Sætvedt's solid experience from international corporate finance, Harstad's
international leadership experience in addition to support from the new Board of
Directors, we feel confident the company shall manage its planned international
journey. At the same time, I also want to thank Kristine Rød for her
contributions and commitment to SoftOx and wish her all the best for the
future," said Geir Almås, Executive Chairman of SoftOx. 

For any questions or interview requests, please contact: 
Geir Almås, CEO of SoftOx Solutions AS
Mail: ir@soft-ox.com 
Phone: Front Desk: (+47) 948-59-599 

About SoftOx Solutions AS 
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a medtech and
clinical-stage pharmaceutical company based in Oslo, Norway, with the goal of
reducing the spread of infection and emergence of antimicrobial resistance. 
For more information on SoftOx, visit www.soft-ox.com